Inhalant cannabidiol impedes tumor growth through decreased tumor stemness and impaired angiogenic switch in NCI-H1437-induced human lung cancer model-Reference-Cited by-同舟云学术

Inhalant cannabidiol impedes tumor growth through decreased tumor stemness and impaired angiogenic switch in NCI-H1437-induced human lung cancer model

Published:2023-02-03 Issue:3 Volume:36 Page:1204-1210
ISSN:1749-0774
Container-title:Human Cell
language:en
Short-container-title:Human Cell

Author:

Salles Évila Lopes,Naeini Sahar Emami,Khodadadi Hesam,Bhandari Bidhan,Rezaee Sholeh,Threlkeld Edie,Rogers Hannah M.,Costigliola Vincenzo,Terry Alvin V.,Hess David C.,Deb Sumitra,Deb Swati Palit,Yeudall W. Andrew,Yu Jack C.,Wang Lei P.,Baban Babak^ORCID

Funder

Augusta University

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology

Link

https://link.springer.com/content/pdf/10.1007/s13577-023-00869-8.pdf

Reference15 articles.

1. Sharma P, Mehta M, Dhanjal DS, Kaur S, Gupta G, Singh H, Thangavelu L, Rajeshkumar S, Tambuwala M, Bakshi HA, Chellappan DK, Dua K, Satija S. Emerging trends in the novel drug delivery approaches for the treatment of lung cancer. Chem Biol Interact. 2019;25(309): 108720.

2. Ragavan M, Patel MI. The evolving landscape of sex-based differences in lung cancer: a distinct disease in women. Eur Respir Rev. 2022;31(163): 210100.

3. Li K, Zang X, Meng X, Li Y, Xie Y, Chen X. Targeted delivery of quercetin by biotinylated mixed micelles for non-small cell lung cancer treatment. Drug Deliv. 2022;29(1):970–85.